Table 1 Patient characteristics and COST values (N = 421)
From: Potential profile analysis of financial toxicity and its related factors among lung cancer patients
Characteristic | N (%) | COST M (Q1,Q3) | Z/H Value | P |
|---|---|---|---|---|
Age (Years) | 13.412** | 0.004 | ||
≤ 45 | 15 (3.6) | 15 (9,32) | ||
46 ~ 60 | 166 (39.4) | 13 (7,22) | ||
61 ~ 75 | 214 (50.8) | 17 (10,24.25) | ||
> 75 | 26 (6.2) | 20 (13.5,29.5) | ||
Sex | − 0.482* | 0.630 | ||
Male | 292 (69.4) | 16 (9,24) | ||
Female | 129 (30.6) | 16 (9,23) | ||
Residence | 27.035** | < 0.001 | ||
Urban | 102 (24.2) | 22 (13,32) | ||
Rural | 319 (75.8) | 14 (8,22) | ||
Medical Expense Insurance | 64.780** | < 0.001 | ||
New Rural Cooperative Medical Insurance | 260 (61.8) | 13 (7,19) | ||
Medical Insurance for Urban Residents | 26 (6.2) | 20 (8.75,27.25) | ||
Medical Insurance for Urban Workers | 133 (31.6) | 23 (15,31) | ||
Employment Status | 63.431** | < 0.001 | ||
On the job | 58 (13.8) | 17 (11.75,22.5) | ||
Retired | 119 (28.3) | 23 (15,31) | ||
Unemployed | 244 (58.0) | 12 (7,19) | ||
Education Level | 33.747** | < 0.001 | ||
Primary School or Below | 174 (41.3) | 14 (8,20) | ||
Junior High School/Technical Secondary School | 150 (35.6) | 15 (8,24) | ||
Minimum of Senior High School | 67 (15.9) | 20 (13,28) | ||
Junior College or Above | 30 (7.1) | 24 (18,34.5) | ||
Reimbursement Ratio | ||||
≤ 50% | 164 (39.0) | 12 (7.25,17) | 66.923** | < 0.001 |
50% ~ 75% | 150 (35.6) | 14.5 (8,23) | ||
> 75% | 107 (25.4) | 24 (18,32) | ||
Household Monthly Income/Person (Yuan) | 53.013** | < 0.001 | ||
≤ 1000 | 177 (42.0) | 12 (7,19) | ||
1000 ~ 2999 | 105 (24.9) | 16 (10,24) | ||
3000 ~ 4999 | 70 (16.6) | 18.5 (10.75,26.25) | ||
5000 ~ 9999 | 49 (11.6) | 24 (15,30) | ||
> 10,000 | 20 (4.8) | 27.5 (15.25,36.75) | ||
Length of Cancer Diagnosis | 4.563** | 0.207 | ||
≤ 1 Year | 309 (73.4) | 17 (10,25) | ||
1 ~ 5 Years | 97 (23.0) | 15 (7,22) | ||
5 ~ 10 Years | 11 (2.6) | 13 (4,25) | ||
> 10 Years | 4 (1.0) | 11.5 (2.5,20.5) | ||
Number of Hospitalizations | 8.621** | 0.035 | ||
≤ 3 | 117 (27.8) | 17 (11,29) | ||
3 ~ 10 | 162 (38.5) | 15 (8,24) | ||
10 ~ 20 | 59 (14.0) | 19 (7,26) | ||
> 20 | 79 (18.8) | 15 (10,21) | ||
Pathological Pattern | 4.392** | 0.356 | ||
Squamous Cell Carcinoma | 84 (20.0) | 17 (11.25,24) | ||
Adenocarcinoma | 212 (50.4) | 15 (8,23) | ||
Adenosquamous Carcinoma | 5 (1.2) | 13 (6,23) | ||
Other Neuroendocrine Tumors | 12 (2.9) | 14 (2.5,27.75) | ||
Small Cell Cancer | 105 (24.9) | 17 (9.5,25) | ||
Other | 3 (0.7) | 12 | ||
Cancer Stage | 3.112** | 0.375 | ||
I | 13 (3.1) | 20 (8,33) | ||
II | 32 (7.6) | 16.5 (11,26.5) | ||
III | 116 (27.6) | 17 (12,24) | ||
IV | 260 (61.8) | 15 (8,23) | ||
Change Life Style | − 5.783* | < 0.001 | ||
Yes | 383 (90.97) | 15 (9,23) | ||
No | 38 (9.03) | 29 (19.75,36.25) | ||
Change of Medical Plan | − 6.680* | < 0.001 | ||
Yes | 37 (9.64) | 6 (4,10) | ||
No | 384 (90.36) | 17 (10,24) | ||
Ask Others for Help | − 8.225* | < 0.001 | ||
Yes | 154 (36.58) | 11 (5,17) | ||
No | 267 (63.42) | 19 (12,29) | ||
Access to Medical Assistance | − 1.873* | 0.061 | ||
Yes | 9 (2.14) | 7 (1.5,19.5) | ||
No | 412 (97.86) | 16 (9,24) | ||
Commercial Insurance | − 1.742* | 0.082 | ||
Yes | 79 (18.76) | 18 (10,30) | ||
No | 342 (81.24) | 15.5 (9,23) |